UBS Group’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Buy |
+3,742
| New | +$10.3K | ﹤0.01% | 7527 |
|
|
2025
Q1 | – | Sell |
-733
| Closed | -$10.1K | – | 8843 |
|
|
2024
Q4 | $10.1K | Buy |
733
+656
| +852% | +$9.06K | ﹤0.01% | 7080 |
|
|
2024
Q3 | $1.05K | Buy |
+77
| New | +$1.05K | ﹤0.01% | 7516 |
|
|
2024
Q2 | – | Hold |
0
| – | -$6 | – | 8253 |
|
|
2024
Q1 | – | Hold |
0
| – | -$15 | – | 7959 |
|
|
2023
Q4 | – | Hold |
0
| – | -$33 | – | 7874 |
|
|
2023
Q3 | – | Hold |
0
| – | -$105 | – | 7916 |
|
|
2023
Q2 | – | Hold |
0
| – | -$113 | – | 7412 |
|
|
2023
Q1 | – | Hold |
0
| – | -$244 | – | 8118 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9082 |
|
|
2022
Q3 | – | Sell |
-13
| Closed | -$16K | – | 9258 |
|
|
2022
Q2 | $16K | Hold |
13
| – | – | ﹤0.01% | 6144 |
|
|
2022
Q1 | $15K | Sell |
13
-49
| -79% | -$56.5K | ﹤0.01% | 6774 |
|
|
2021
Q4 | $73K | Buy |
+62
| New | +$73K | ﹤0.01% | 5484 |
|